The role of systemic inflammation in remnant cholesterol-associated cardiovascular risk: insights from the EPIC-Norfolk study
This study finds that systemic inflammation does not influence the effect remnant cholesterol has on cardiovascular disease risk, suggesting the importance of addressing both remnant cholesterol and inflammation to manage cardiovascular health.
Authors
- G. Kees Hovingh (ORCID: https://orcid.org/0000-0002-8145-1676)
- Jordan M Kraaijenhof (ORCID: https://orcid.org/0000-0001-7566-6403)
- Aldo Grefhorst (ORCID: https://orcid.org/0000-0003-1761-9494)
- Nick S. Nurmohamed (ORCID: https://orcid.org/0000-0001-9045-6009)
- Jeffrey Kroon (ORCID: https://orcid.org/0000-0001-9983-6614)
- Laurens F. Reeskamp (ORCID: https://orcid.org/0000-0002-8043-951X)
- Erik S.G. Stroes (ORCID: https://orcid.org/0000-0001-9555-6260)
- S. Matthijs Boekholdt (ORCID: https://orcid.org/0000-0002-0861-0765)
- Nicholas J. Wareham (ORCID: https://orcid.org/0000-0003-1422-2993)
- Marije Kerkvliet
Institutions
- Amsterdam University Medical Centers (NL)
- MRC Epidemiology Unit (GB)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
- Medical Research Council (GB)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1093/eurjpc/zwaf037
- Citations
- 18
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 24.38